<ѻý>JAK Inhibitor Misses Endpoint in Safety Study. Now What?ѻý> Major blow to popular class of oral rheumatology drugs Jan 27, 2021
<ѻý>Montana Oncologist Fired for Misdiagnosing, Overtreating Patientsѻý> But some rally around him Jan 26, 2021
<ѻý>Telehealth's Security Problem; Virtual Cancer Care; Post-Pandemic Teladocѻý> Emerging trends in telemedicine and telehealth Jan 25, 2021
<ѻý>Ozempic Seeking High Dose OK; Thyroid Cancer Overdiagnosed in Kids?ѻý> News and commentary from the endocrinology world Jan 24, 2021
<ѻý>Aspirin and CRC Risk: A Curious Age Connectionѻý> Implications for prophylactic recommendations, researchers say Jan 21, 2021
<ѻý>Cancer and COVID; Booze and Cancer; 'Screech' Starts Chemoѻý> News, features, and commentary about cancer-related issues Jan 21, 2021
<ѻý>Kardashian Makeup Artist Hrush Achemyan's Ovarian Cancerѻý> Beauty influencer reveals diagnosis Jan 21, 2021
<ѻý>Oncotype DX Misses on Breast Cancer Risk in Black Womenѻý> Accuracy of 21-gene recurrence score worse compared with white women Jan 21, 2021
<ѻý>Not Just BRCA: Large Studies ID Other Key Breast Cancer Risk Genesѻý> Implications for screening and other risk-management strategies, researchers say Jan 20, 2021
<ѻý>Preop RT Flunks Test in Borderline Pancreatic Cancerѻý> Chemotherapy alone judged efficacious but not chemoradiation Jan 20, 2021
<ѻý>Drug Hits Target in Advanced Biliary Cancerѻý> Responses in up to a third of patients with FGFR inhibitor infigratinib Jan 19, 2021
<ѻý>Liquid Biopsy Predicts Colon Cancer Relapse Months Before CTѻý> Test for ctDNA outperformed existing biomarker, may help guide therapy Jan 17, 2021
<ѻý>New Target to Attack in Stomach Cancerѻý> PFS, OS improved with fibroblast growth factor receptor inhibitor in non-HER2 disease Jan 16, 2021
<ѻý>Ethics Consult: Refuse Treatment for Dictator? MD/JD Weighs Inѻý> You voted, now see the results and an expert's discussion Jan 15, 2021
<ѻý>Copay Assistance Programs Help Patients but Confuse Them Tooѻý> Insurers keep track of their use and in some cases won't apply them to patient deductibles Jan 13, 2021
<ѻý>Nuanced View of Oral Sex, HPV+ Oropharyngeal Cancerѻý> Age at first oral sex, 'intensity,' number of partners all influence risk Jan 13, 2021
<ѻý>Is This Really Cancer?ѻý> Movement builds to classify Gleason 6 prostate lesions as nonmalignant Jan 09, 2021
<ѻý>Most Women Satisfied With 'Going Flat' After Mastectomyѻý> Lack of surgeon support key factor in later dissatisfaction, study shows Jan 08, 2021
<ѻý>Medicare's 'Most Favored Nation' Drug-Pricing Rule in Limboѻý> Rule affecting Part B drugs was to take effect Jan. 1 but was stopped by federal court orders Jan 07, 2021
<ѻý>Targeted Combo Fails in EGFR-Mutant NSCLCѻý> Osimertinib-bevacizumab no better than osimertinib alone Jan 07, 2021
<ѻý>Baby Boys Get Cancer From Mom During Birthѻý> Report highlights potential fetal implications of undiagnosed maternal cervical cancer Jan 06, 2021
<ѻý>PARP Inhibitors Linked With Blood Cancer Riskѻý> Incidence of MDS/AML under 1%, but further investigation warranted as indications broaden Dec 28, 2020
<ѻý>Young-Onset Esophageal Cancer Rapidly Increasingѻý> Physicians should be on the alert for younger patients with dysphagia, researchers urge Dec 16, 2020
<ѻý>Add-On HDAC Inhibitor No Help in Breast Cancerѻý> PFS, OS similar to endocrine therapy alone for advanced HR+ disease Dec 15, 2020
<ѻý>Broader Role for PARP Inhibitors in Breast Cancer?ѻý> Responses in tumors with somatic or germline mutations related to HRD Dec 14, 2020
<ѻý>Online Tool Refines Individual Risks in Breast Cancerѻý> RSClin incorporates 21-gene recurrence score with tumor grade, size, and more Dec 13, 2020
<ѻý>Doctor-Patient Discord in Reporting Radiation Toxicityѻý> Physicians underrecognized substantial symptoms in more than half of patients Dec 11, 2020
<ѻý>Non-Hodgkin Lymphoma: Bispecific Antibodies Impress in Refractory Diseaseѻý> Odronextamab, epcoritamab surpass 90% response threshold in early trials Dec 11, 2020
<ѻý>Adjuvant Palbociclib Fails in Early, High-Risk Breast Cancerѻý> No iDFS benefit with 1 year of CDK4/6 inhibition following neoadjuvant chemotherapy Dec 10, 2020
<ѻý>Chemo-Free Combo Boosts PFS in First-Line CLLѻý> PI3K-delta-based regimen also topped chemoimmunotherapy in relapsed setting Dec 08, 2020
<ѻý>Novel Agent Active in Refractory CMLѻý> Asciminib doubles molecular response versus bosutinib after two or more prior lines of therapy Dec 08, 2020
<ѻý>High-Risk Prostate Cancer Patients Can Wait 6 Months for Surgery: Studyѻý> Can be considered low priority procedure during COVID-19 pandemic, researchers say Dec 08, 2020
<ѻý>Gene Therapy Stops Bleeding in Hemophiliaѻý> Single injection had durable effectiveness, study showed Dec 08, 2020
<ѻý>Chemotherapy Improved TNBC Survival in Older Womenѻý> Benefits noted in both node-negative and -positive disease, as well as for those with a comorbidity score greater than 0 Dec 08, 2020
<ѻý>Tranexamic Acid May Hurt Head Trauma Survival for One Key Groupѻý> Cheap antifibrinolytic given en route to hospital safe overall in registry Dec 07, 2020
<ѻý>Fixed-Duration Ibrutinib-Venetoclax Promising in First-Line CLLѻý> DFS at 1 year reaches 95% in patients with undetectable MRD Dec 06, 2020
<ѻý>CRISPR-Based Tx Offers Hope in Tough-to-Treat Blood Disordersѻý> Success with investigational use of gene editing in sickle cell disease, beta-thalassemia Dec 06, 2020
<ѻý>Blood Cancers and COVID-19: 'A Medically Vulnerable' Groupѻý> Patients with hematologic malignancies and SARS-CoV-2 face higher risks for infection, death Dec 06, 2020
<ѻý>JAK Inhibitor Wins in Second-Line Chronic GVHDѻý> Twice as many patients achieved a response at week 24 Dec 05, 2020
<ѻý>Sickle Cell Disease Tied to Worse COVID-19 Outcomesѻý> Black patients seem to be at higher risk for certain COVID-19 complications, death Dec 05, 2020